Company Filing History:
1 out of 1 
1 out of 832,966 Years Active: 2011-2016
Title: Thomas Borén: Innovator in Cereal Products and Immunology
Introduction
Thomas Borén is a notable inventor based in Umeå, Sweden. He has made significant contributions to the fields of food technology and immunology. With a total of 2 patents, his work focuses on innovative solutions for health-related issues.
Latest Patents
One of Borén's latest patents is for a fermented cereal product obtained by fermentation of rye bran with a Lactobacillus curvatus strain. This invention presents a non-antibiotic therapeutic strategy for inhibiting oro-gastro-intestinal infections and pathogens. It particularly addresses adherence and colonization in the gastrointestinal channel, aiming to prevent or relieve associated oro-gastro-intestinal diseases. The invention also relates to methods and products based on an active cereal product or ferric quinate, applicable to various oro-gastro-intestinal pathogens in both humans and animals.
Another significant patent involves materials and methods for the prevention, treatment, and diagnosis of infections caused by specific pathogens. This invention introduces new specific variable antibody regions and derivatives, including the fully human immunoglobulin, Abba3, which exhibits specific activity to the BabA antigen. The patent outlines methods for the production, isolation, and use of these immunoglobulins, including their application in disease detection and immunization therapies.
Career Highlights
Throughout his career, Thomas Borén has worked with various companies, including Helicure AB. His innovative approaches have led to advancements in both food technology and immunology, showcasing his versatility as an inventor.
Collaborations
Borén has collaborated with notable individuals in his field, including Göran Hallmans and Per Åman. These partnerships have contributed to the development of his groundbreaking inventions.
Conclusion
Thomas Borén is a distinguished inventor whose work in cereal products and immunology has the potential to impact health positively. His innovative patents reflect a commitment to addressing significant health challenges through creative solutions.